The National Health Service (NHS) has reminded people over the age of 40 that they are at an increased risk of developing ...

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2024 with a number of leading business and industry ...

Icon Plc and Medpace are both CROs, but Icon focuses on large pharma with an aggressive M&A strategy, unlike Medpace's small biotech focus. Initially impressed by Icon's financials, we purchased ...

Earnings Estimate Revisions for Icon PLC This contract research organization is expected to earn $15.07 per share for the fiscal year ending December 2024, which represents a year-over-year change ...

DUBLIN 18, Ireland (AP) — Icon PLC (ICLR) on Wednesday reported first-quarter earnings of $154.2 million. The Dublin 18, Ireland-based company said it had profit of $1.90 per share. Earnings ...

A month has gone by since the last earnings report for Icon PLC (ICLR). Shares have lost about 8.9% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...

Ross Monaghan looked like any other parent as he joined mums and dads on the Monday morning school run. He had just dropped his daughter off when he was approached by what appeared to be another ...

Analyst Price Forecast Suggests 47.20% Upside As of April 24, 2025, the average one-year price target for ICON Public Limited is $213.44/share. The forecasts range from a low of $158.57 to a high ...

Investors might want to bet on Icon PLC (ICLR), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of ...